SCHEMBL18563259

SCHEMBL18563259

c1ccc(-c2ccc(N(c3ccc4c(c3)Oc3ccccc3O4)c3ccc4c(c3)Oc3ccccc3O4)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.42
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
CA12 O43570 1/20 0.36
CA9 Q16790 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
GAA P10253 1/20 0.35
NTSR1 P30989 1/20 0.33
GPR55 Q9Y2T6 1/20 0.33
PTGS2 P35354 1/20 0.33
CA1 P00915 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18563290 1.00 AHR (0.42) AHRALDH1A1KDM4EL3MBTL1CYP1A2
SCHEMBL18563227 1.00 AHR (0.42) AHRALDH1A1KDM4EL3MBTL1CYP1A2
SCHEMBL18563248 0.98 AHR (0.41) AHRALDH1A1KDM4EL3MBTL1CYP1A2
SCHEMBL16787289 0.93 AHR (0.42) AHRALDH1A1KDM4EL3MBTL1CYP1A2
SCHEMBL18563243 0.92 AHR (0.37) AHRALDH1A1KDM4EL3MBTL1CYP1A2
SCHEMBL16787279 0.91 AHR (0.41) AHRALDH1A1KDM4EL3MBTL1CYP1A2
SCHEMBL18563199 0.90 AHR (0.47) AHRALDH1A1KDM4EL3MBTL1CYP1A2
SCHEMBL18563297 0.90 AHR (0.47) AHRALDH1A1KDM4EL3MBTL1CYP1A2
SCHEMBL12259304 0.89 ALDH1A1 (0.38) AHRALDH1A1KDM4EL3MBTL1CYP1A2
SCHEMBL2389199 0.89 ALDH1A1 (0.38) AHRALDH1A1KDM4EL3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10361373-B2 Condensed-cyclic compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2019-07-23 US disclosed
US-20170062720-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-03-02 US disclosed
US-20170062720-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-03-02 US disclosed
EP-3135673-A2 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME Samsung Display Co., Ltd. (KR) 2017-03-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170062720-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LRRK2, SLC18A1, CCNT1 AHR 2829/4885ALDH1A1 832/4885KDM4E 1389/4885
US-10361373-B2 Condensed-cyclic compound and organic light emitting device comprising the same LRRK2, SLC18A1, CCNT1 AHR 2829/4885ALDH1A1 832/4885KDM4E 1389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.